New Era Energy & Digital plans a 1GW Texas data center but lacks cash, experience, and tenants; big dilution risk. See here ...
Nvidia’s $20 billion strategic licensing deal with Groq represents one of the first clear moves in a four-front fight over ...
AI’s true promise is turning clinical development from a bottleneck into a throughput engine for human health. Drug discovery ...
Avinasi Labs Enables a New Funding & Revenue Model for Clinical Stage Assets via DeLong Protocol SAN FRANCISCO, CA, UNITED STATES, December 31, 2025 /EINPresswire.com/ — Avinasi Labs, an AI-native ...
In 2026, healthcare will embrace the model context protocol, deploy better documentation tools that boost reimbursement and ...
If you look at the last decade of AI progress, most of it has been measured in a single dimension: bigger models and better benchmarks. That approach worked for a while, but we’re now running into the ...
The honeymoon phase with generative AI is officially over. The "shadow AI" behaviors we feared in 2024, like pasting ...
More accurate and individualized health predictions will allow for preventative factors to be implemented well in advance.
On December 16, 2025, analyst confidence in Palvella Therapeutics, Inc. (NASDAQ:PVLA) was seen rising, as the company announced encouraging Phase 2 data for QTORIN rapamycin in cutaneous venous ...
Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive ...
The companies that will define the next phase of AI are the ones already—without prompting from policymakers—building ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback